Galera Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
GRTX on OTC
Location
45 Liberty Blvd., Suite 230, Malvern, PA

Insiders trading volume in the past year

Galera Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yair Schneid 10%+ Owner $2.1M +$696K +49.6% Apr 17, 2024
Rochel Soffer 10%+ Owner $1.15M Apr 16, 2024
Altamont Pharmaceutical Holdings, LLC 10%+ Owner $158K -$812K -83.7% Dec 31, 2023
Mel Sorensen President and CEO, Director $19.1K -$4.83K -20.2% Aug 16, 2024
Mark Bachleda Chief Commercial Officer $11.8K Mar 16, 2023
Chris Degnan Chief Financial Officer $10.7K Mar 13, 2023
Linda West Director Jul 1, 2023
Emmett Cunningham Director Jun 14, 2023
Eugene P. Kennedy Chief Medical Officer Feb 25, 2023
Holmlund Jon T Chief Medical Officer Feb 28, 2022
Kevin G. Lokay Director Jun 14, 2023
Michael Powell Director Jun 14, 2023
Robert A. Beardsley Chief Operating Officer Feb 25, 2023
Jennifer Evans Stacey Chief Legal & Compliance Officer Feb 25, 2023
Lawrence M. Alleva Director Jul 1, 2023

Recent Insider Transactions by Companies or Individuals for Galera Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.